politics #HealthCare #Policy #Alzheimer'sDiseaseInternational #Alzheimer’s #GLP1 #NovoNordisk #WeightLossDrugs GLP-1s fail to slow progression of Alzheimer’s: Novo Nordisk The Hill Tue The trials showed an effect on Alzheimer's biomarkers, though Novo did not specify which ones. thehill.com
BURST